Acrylic Acid

Acrylic Acid

SCHEMBL29670985

C=CC(=O)O.C=CC(=O)O.C=CC(=O)O.C=CC(=O)O.CCCC(CO)(CO)CO.CCCC(CO)(CO)CO

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
ALDH1A1 P00352 3/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 1/20 0.41
TSHR P16473 3/20 0.36
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HPGD P15428 1/20 0.32
THRB P10828 1/20 0.31
ZDHHC20 Q5W0Z9 1/20 0.31
ZDHHC2 Q9UIJ5 1/20 0.31
CHRM1 P11229 1/20 0.30
AKR1A1 P14550 1/20 0.30
CHRM3 P20309 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
ADRA1A P35348 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid SCHEMBL11317649 1.00 LMNA (0.43) LMNAALDH1A1TP53CYP3A4MAPK1
Acrylic Acid SCHEMBL31043062 1.00 LMNA (0.43) LMNAALDH1A1TP53CYP3A4MAPK1
Acrylic Acid SCHEMBL30415630 1.00 LMNA (0.43) LMNAALDH1A1TP53CYP3A4MAPK1
Acrylic Acid SCHEMBL30144086 1.00 LMNA (0.43) LMNAALDH1A1TP53CYP3A4MAPK1
Acrylic Acid SCHEMBL30415767 0.88 LMNA (0.40) LMNAALDH1A1TP53CYP3A4MAPK1
Acrylic Acid SCHEMBL1726728 0.87 ZDHHC20 (0.37) LMNAALDH1A1TP53CYP3A4MAPK1
Acrylic Acid SCHEMBL29670996 0.86 ZDHHC20 (0.39) LMNAALDH1A1TP53CYP3A4MAPK1
Acrylic Acid SCHEMBL29670988 0.86 ZDHHC20 (0.39) LMNAALDH1A1TP53CYP3A4MAPK1
Acrylic Acid SCHEMBL29624628 0.84 LMNA (0.46) LMNAALDH1A1TP53CYP3A4MAPK1
Acrylic Acid SCHEMBL27771773 0.84 LMNA (0.46) LMNAALDH1A1TP53CYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250155808-A1 RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN ZEON CORPORATION (JP) 2025-05-15 US disclosed
WO-2024070672-A1 RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN 日本ゼオン株式会社 2024-04-04 WO disclosed
WO-2023189969-A1 RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN 日本ゼオン株式会社 2023-10-05 WO disclosed
EP-3932906-B1 NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, AND CURED OBJECT ADEKA CORP (JP) 2023-07-12 EP disclosed
US-11667609-B2 Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product ADEKA CORPORATION (JP) 2023-06-06 US disclosed
US-20220153698-A1 NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, SELF-HEALING MATERIAL, SURFACE COATING AGENT, PAINT, ADHESIVE, MATERIAL FOR BATTERY AND CURED PRODUCT ADEKA CORPORATION (JP) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667609-B2 Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product H1-0, H1-10, RAD51 LMNA 2828/4885ALDH1A1 323/4885TP53 2667/4885
US-20220153698-A1 NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, SELF-HEALING MATERIAL, SURFACE COATING AGENT, PAINT, ADHESIVE, MATERIAL FOR BATTERY AND CURED PRODUCT H1-0, H1-10, RAD51 LMNA 3038/4885ALDH1A1 367/4885TP53 2848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.